Overview

Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers

Status:
Completed
Trial end date:
2017-01-12
Target enrollment:
Participant gender:
Summary
This is the first clinical trial to evaluate ascending multiple oral doses in healthy adult and healthy elderly subjects to characterize the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BIIB118
Phase:
Phase 1
Details
Lead Sponsor:
Biogen
Pfizer
Treatments:
Melatonin